Moreover, the IPA analyses clearly indicated that the AML pathway was significantly deregulated in our samples, and showed that RUNX1, SIN3A, or TCF12 have a crucial impact on differentially expressed genes. This evidence concerns the gene TCF12 and acute myeloid leukemia.